Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

82.92 +0.29 (+0.35%)
Streaming Delayed Price Updated: 12:48 PM EDT, Jul 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,000,395
Open 82.91
Bid (Size) 82.91 (7)
Ask (Size) 82.92 (6)
Prev. Close 82.63
Today's Range 82.17 - 83.58
52wk Range 73.31 - 127.99
Shares Outstanding 2,531,374,696
Dividend Yield 3.91%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Merck Stock Slipped Today
A change in full-year guidance by management wasn't particularly welcome. 
Via The Motley Fool
Is Merck & Co Gaining or Losing Market Support?
 
Via Benzinga

Performance

YTD
-16.4%
-16.4%
1 Month
+4.7%
+4.7%
3 Month
-2.1%
-2.1%
6 Month
-14.9%
-14.9%
1 Year
-35.1%
-35.1%

More News

Read More
Why Merck (MRK) Shares Are Sliding Today
Via StockStory
Topics Artificial Intelligence Workforce
Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges
Via Benzinga
Earnings Scheduled For July 29, 2025
Via Benzinga
Merck & Co's Earnings Outlook
Via Benzinga
P/E Ratio Insights for Merck & Co
Via Benzinga
AMD Rises To 1-Year Highs, Crude Eyes $68: What's Moving Markets Tuesday?
Via Benzinga
These S&P500 stocks are gapping in today's session
Via Chartmill
Merck’s Full Year Guidance Disappoints Investors But Retail Pins Hopes On $3B Cost-Cutting Plan
Via Stocktwits
Topics World Trade
Which S&P500 stocks are moving before the opening bell on Tuesday?
Via Chartmill
Merck Posts Q2 EPS Beat Revenue Slips
Via The Motley Fool
Merck’s (NYSE:MRK) Q2 Earnings Results: Revenue In Line With Expectations
Via StockStory
Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results
From Merck & Co., Inc.
Via Business Wire
Got $1,000? 3 High-Yield Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
Topics Lawsuit
After Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact
Via Benzinga
How To Earn $500 A Month From Merck Stock Ahead Of Q2 Earnings
Via Benzinga
3 Surprisingly Underrated Stocks to Buy Right Now
Via The Motley Fool
Topics Intellectual Property
What To Expect From Merck’s (MRK) Q2 Earnings
Via StockStory
Topics Artificial Intelligence
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pills
Via Benzinga
Topics Artificial Intelligence ETFs
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharma
Via Benzinga
Merck & Co. Inc. (NYSE:MRK): A Strong Value Investment with Undervalued Potential
Via Chartmill
Abivax Hits The Stratosphere, Up 500%, On 'Potentially Disruptive' Results
Via Investor's Business Daily
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
Via Investor's Business Daily
Merck Announces Fourth-Quarter 2025 Dividend
From Merck & Co., Inc.
Via Business Wire

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 82.92
When was Merck & Co last traded?
The last trade of Merck & Co was at 07/30/25 12:48 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 209.90B
How many shares of Merck & Co are outstanding?
Merck & Co has 210B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.